Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 5Y Ago
-7.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.15% |
| Q3 2025 | 13.47% |
| Q2 2025 | 89.54% |
| Q1 2025 | -180.30% |
| Q4 2024 | -138.82% |
| Q3 2024 | 63.56% |
| Q2 2024 | -116.13% |
| Q1 2024 | 7.07% |
| Q4 2023 | -6.13% |
| Q3 2023 | -12.73% |
| Q2 2023 | 19.81% |
| Q1 2023 | -4.79% |
| Q4 2022 | -16.70% |
| Q3 2022 | -9.79% |
| Q2 2022 | 12.32% |
| Q1 2022 | -19.86% |
| Q4 2021 | 13.16% |
| Q3 2021 | -98.22% |
| Q2 2021 | -11.46% |
| Q1 2021 | -40.59% |
| Q4 2020 | 0.82% |
| Q3 2020 | -2.77% |
| Q2 2020 | 28.08% |
| Q1 2020 | -82.56% |
| Q4 2019 | 36.27% |
| Q3 2019 | -15.32% |
| Q2 2019 | 19.09% |
| Q1 2019 | 1.60% |
| Q4 2018 | -24.13% |
| Q3 2018 | -13.45% |
| Q2 2018 | 9.20% |
| Q1 2018 | -16.66% |
| Q4 2017 | 4.82% |
| Q3 2017 | 11.56% |
| Q2 2017 | -4.67% |
| Q1 2017 | -30.35% |
| Q4 2016 | -6.81% |
| Q3 2016 | 7.39% |
| Q2 2016 | 2.67% |
| Q1 2016 | -1648.12% |